The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients: The MARI Procedure
Open accessAbstract
In Brief Objective: The MARI procedure [marking the axillary lymph node with radioactive iodine (125I) seeds] is a new minimal invasive method to assess the pathological response of nodal metastases after neoadjuvant systemic treatment (NST) in patients with breast cancer. This method allows axilla-conserving surgery in patients responding well to NST. Methods: Prior to NST, proven tumor-positive axillary lymph nodes were marked with a 125I seed. This marked lymph node is the so-called MARI-node. After NST, the MARI node was selectively removed using a γ-detection probe. A complementary axillary lymph node dissection was performed in all patients to assess whether pathological response in the MARI node was indicative for the pathological response in the additional lymph nodes. Results: A tumor-positive axillary lymph node was marked with a 125I seed in 100 patients. The MARI node was successfully identified in 97 of these 100 patients (identification rate 97%). Two patients did not undergo subsequent axillary lymph node dissection, leaving 95 patients for further analysis. The MARI node contained residual tumor cells in 65 of these 95 patients. In the other 30 patients, the MARI node was free of tumor, but additional positive lymph nodes were found in 5 patients. Thus, the MARI procedure correctly identified 65 of 70 patients with residual axillary tumor activity (false negative rate 5/70 = 7%). Conclusions: This study shows that marking and selectively removing metastatic lymph nodes after neoadjuvant systemic treatment has a high identification rate and a low false negative rate. The tumor response in the marked lymph node may be used to tailor further axillary treatment after NST. The MARI procedure (marking the axillary lymph node with radioactive iodine seeds) is a new minimal invasive method to assess the pathological response of nodal metastases after neoadjuvant systemic treatment in patients with breast cancer. The tumor response in the marked lymph node may be used to tailor further axillary treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giuliano, A. E. (2011) · JAMA · doi:10.1001/jama.2011.90 · Cited by 2,942
Boughey, J. C. (2013) · JAMA · doi:10.1001/jama.2013.278932 · Cited by 1,588
Kuehn, T., Bauerfeind, I., Fehm, T., Fleige, B., Hausschild, M., Helms, G., Lebeau, A., Liedtke, C., Minckwitz, G. V., Nekljudova, V., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70166-9 · Cited by 1,485
Galimberti, V., Cole, B. F., Zurrida, S., Viale, G., Luini, A., Veronesi, P., Baratella, P., Chifu, C., Sargenti, M., Intra, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70035-4 · Cited by 1,233
Neoadjuvant chemotherapy for operable breast cancer
Mieog, J. S. D., van der Hage, J. A., & van de Velde, C. J. H. (2007) · British Journal of Surgery · doi:10.1002/bjs.5894 · Cited by 433
Gray, R. J., Salud, C., Nguyen, K., Dauway, E., Friedland, J., Berman, C., Peltz, E., Whitehead, G., & Cox, C. E. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0711-3 · Cited by 326
Loo, C. E., Straver, M. E., Rodenhuis, S., Muller, S. H., Wesseling, J., Vrancken Peeters, M.-J. T. F. D., & Gilhuijs, K. G. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1258 · Cited by 304
Self-citationvan Deurzen, C. H. M., Vriens, B. E. P. J., Tjan-Heijnen, V. C. G., van der Wall, E., Albregts, M., van Hilligersberg, R., Monninkhof, E. M., & van Diest, P. J. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.08.001 · Cited by 208
Changes in Gene Expression Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer
Hannemann, J., Oosterkamp, H. M., Bosch, C. A. J., Velds, A., Wessels, L. F. A., Loo, C., Rutgers, E. J., Rodenhuis, S., & van de Vijver, M. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.077 · Cited by 205
Self-citationIs 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis
Wang, Y., Zhang, C., Liu, J., & Huang, G. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1780-z · Cited by 167
Cited by
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz173 · Cited by 2,214
Boughey, J. C., Ballman, K. V., Le-Petross, H. T., McCall, L. M., Mittendorf, E. A., Ahrendt, G. M., Wilke, L. G., Taback, B., Feliberti, E. C., & Hunt, K. K. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001375 · Cited by 457
Axillary Nodal Evaluation in Breast Cancer: State of the Art
Chang, J. M., Leung, J. W. T., Moy, L., Ha, S. M., & Moon, W. K. (2020) · Radiology · doi:10.1148/radiol.2020192534 · Cited by 387
Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review
Pilewskie, M., & Morrow, M. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4163 · Cited by 262
Metadata
- Authors
- Donker, M., Straver, M. E., Wesseling, J., Loo, C. E., Schot, M., Drukker, C. A., van Tinteren, H., Sonke, G. S., Rutgers, E. J. T., & Vrancken Peeters, M.-J. T. F. D.
- Venue
- Annals of Surgery
- Published
- 2015-02
- Volume
- 261
- Issue
- 2
- Pages
- 378-382
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2012620884
- Cited by
- 429
- References
- 14
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients: The MARI Procedure. https://app.cochat.ai/papers/10.1097/sla.0000000000000558
- The paper
- Donker, M., Straver, M. E., Wesseling, J., Loo, C. E., Schot, M., Drukker, C. A., van Tinteren, H., Sonke, G. S., Rutgers, E. J. T., & Vrancken Peeters, M.-J. T. F. D. (2015). Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients: The MARI Procedure. Annals of Surgery. https://doi.org/10.1097/sla.0000000000000558
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.